RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+12.88%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.12B
AUM Growth
+$1.12B
(+22%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
11.06%
Top 10 Holdings %
Top 10 Hldgs %
31%
Holding
95
New
1
Increased
36
Reduced
12
Closed
13
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$42.2M |
| 2 |
Medtronic
MDT
|
$9.35M |
| 3 |
Eli Lilly
LLY
|
$8.88M |
| 4 |
Cigna
CI
|
$6.78M |
| 5 |
Cooper Companies
COO
|
$6.74M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$20.3M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$7.48M |
| 3 |
Bristol-Myers Squibb
BMY
|
$5.43M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$4.76M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$4.27M |
Sector Composition
| 1 | Healthcare | 94.2% |
| 2 | Communication Services | 2.08% |
| 3 | Industrials | 0.52% |
| 4 | Technology | 0.02% |
| 5 | Energy | 0.02% |
